Publication Beamlines Strategic Pillar
Okbinoglu; Tulin; Kennepohl; Pierre (2020). The Nature of S-N Bonding in Sulfonamides and Related Compounds: Insights into π-Bonding Contributions from Sulfur K-Edge XAS. Patent Number: 10.26434/chemrxiv.13204985.v1. SXRMB
Wallweber, H.; Mortara, K.; Ferri, E.; Rudolph, J.; Wang, W. et al. (2020). Structure of apo unphosphorylated IRE1. Protein Data Bank: 6w3b. CMCF-ID
Wallweber, H.; Mortara, K.; Ferri, E.; Wang, W.; Rudolph, J. et al. (2020). Structure of phosphorylated apo IRE1. Protein Data Bank: 6w3c. CMCF-ID
Wang, F.; Cheng, W.; Shang, H.; Wang, R.; Zhang, B. et al. (2021). The Crystal Structure of human MTH1 from Biortus. Protein Data Bank: 7esf. CMCF-ID
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
(2021). ANTIBODY. Patent Number: PT3311170T.
(2021). MODELING TEST. Patent Number: PT3311169T.
(2021). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: PT2773671T.
(2020). ANTI-BCMA ANTIBODIES, BIESPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND THEIR USES. Patent Number: PT3337824T.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 요한 프란손; 로빈 매튜 할렛; 모니카 파스쿠알 가르시아 et al. (2021). Combination of LIF inhibitor and PD-1 axis inhibitor for use in treating cancer. Patent Number: KR20210021287A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 파트리샤 앤 깁린; 잔느 마그람 et al. (2021). Combination of LIF inhibitors and platinum-based anti-neoplastic agents for use in treating cancer. Patent Number: KR20210022065A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 피터 에드워드 베일리스; 아지타 제가나탄 et al. (2021). Methods for improving response to anti-LIF antibody treatment in a subject with cancer. Patent Number: KR20210024007A.
한 리; 도로씨아 코미노스; 지에 장; 알라 프리츠커; 매튜 데이비슨 et al. (2020). Antibodies to bradykinin b1 receptor ligands. Patent Number: KR102166083B1.